Yuanda Biotech's Postbiotics Products Get High Industry Attention - Yuanda Biotech Debuts at the 17th International Symposium on Probiotics and Health
2026-04-30 10:19:55
Page views: 1372
Author: 元达生物
2026-04-30 10:19:55
Author: 元达生物

In order to monitor the new trends in the development of the probiotics industry and continuously enhance the endogenous driving force for the healthy development of the industry, the 17th International Symposium on Probiotics and Health, hosted by the Chinese Society for Food Science and Technology, was held in Hangzhou from August 10th to August 12th.
The conference gathers nearly a hundred top talents in the probiotics industry, including academicians, national outstanding youth, Changjiang Scholars, and national outstanding youth, as well as dozens of leading enterprises in the probiotics industry. It is the highest level scientific and technological event in the domestic probiotics industry.

As a global leader in the emerging metaverse industry, Yuanda Biotech, with multiple star products under its umbrella, participated deeply in this year's International Symposium on Probiotics and Health. It is the only high-tech enterprise specializing in the research and industrialization of emerging metaverse among the participating companies, and has received high attention from the conference media, experts, and enterprises.
Gathering industry wisdom and exploring the benefits of health

This conference focuses on industry policies, technological breakthroughs, research and development innovation, and industrial development. Through the most authoritative and forward-looking reports in the field of probiotics, it showcases the latest developments in probiotic research and industry development in China and even the world, jointly embarking on a new journey of technological innovation to promote high-quality development of the industry.
Experts, scholars, and representatives from the probiotics research and industry from all over the country engage in discussions, exchange and share research results, gather wisdom for the development of the probiotics industry, and contribute momentum to the construction of a healthy China.

A major highlight of this conference is the official release of the scientific review "Research Status and Industrial Applications of Postbiotics" nationwide, which is the first consensus statement on the definition, scope, and efficacy of Postbiotics. This means that China has officially entered the era of Postbiotics, and the Postbiotics industry will usher in a period of rapid development. "Mr. Li Zhaojie, co-founder of Yuanda Biology, said that in the trend of consumption upgrading in the post pandemic era, Yuanda Biology has taken the lead in seizing the development trend of Postbiotics, adhered to technology leadership and demand orientation, continued to deepen its cultivation in the field of Postbiotics, continuously developed targeted functional Postbiotics products, deeply integrated with the big health industry, and helped China's big health industry develop with high quality.
Yuanda Biotechnology, continuously exploring and developing future generations through scientific research
As the first technology-based enterprise in China to focus on the research and promotion of probiotic derived metagenomic technology, Yuanda Biotechnology has always been committed to building a leading brand in China's derived metagenomic raw materials and functional derived metagenomic terminal products, and providing a complete set of terminal product solutions such as derived metagenomic functional foods, derived metagenomic skincare products, derived metagenomic functional preservatives, derived metagenomic plant nutrition, and derived metagenomic feed.
The company has gathered a group of industry-leading research talents from the University of Copenhagen in Denmark, Cornell University in the United States, and the University of Macau, continuously cultivating the development and research of emerging industries, establishing a strong and stable supply chain system, and injecting strong impetus into the rapid development of the industry.

With the continuous deepening of epigenetic research, the probiotic industry has entered the era of epigenetic growth. As a young entrepreneur and operator in the emerging industry, Yuanda Biotechnology will not forget its original intention. It will continue to rely on technological innovation to drive product innovation, strengthen product quality management, promote the technological development of the probiotics industry, and inject new impetus into the development of the health industry.

Previous :Yuanda Biotech successfully participated in FIC2022 exhibition in Guangdong
Related News
2026-04-22









